BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4351356)

  • 1. Use of angiotensin II antagonists in experimental hypertension.
    Bumpus FM; Smeby RR; Sweet C; Ferrario CM; Khosla MC
    Circ Res; 1973 May; 32():Suppl 1:150-8. PubMed ID: 4351356
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of synthetic peptide on chronic renal hypertension in the rat.
    Loyke HF
    J Lab Clin Med; 1973 Sep; 82(3):406-11. PubMed ID: 4353878
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of angiotensin antagonists in various forms of experimental arterial hypertension.
    Ferrario CM; Bumpus FM; Masaki Z; Khosla MC; McCubbin JW
    Prog Biochem Pharmacol; 1976; 12():86-97. PubMed ID: 1019172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the renin-system in normo- and hypertension. Effect of angiotensin-inhibitor (1-sar-8-ala-angiotensin II) on the blood pressure of conscious or anaesthetized normal, nephrectomized and renal hypertensive rats.
    Bing J; Nielsen K
    Acta Pathol Microbiol Scand A; 1973 May; 81(3):254-62. PubMed ID: 4358386
    [No Abstract]   [Full Text] [Related]  

  • 5. Antagonists of angiotensin. Effect on the blood pressure of normal and hypertensive rats.
    Saint-Louis J; Regoli D
    Rev Can Biol; 1972 Dec; 31(4):241-51. PubMed ID: 4350595
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of 1-sarcosine, 8-leucyl angiotensin II on the pressor effect of infused angiotensin II.
    O'Connor GJ; Baranowski RL; Kurtzman NA
    Arch Int Pharmacodyn Ther; 1974 May; 209(1):75-9. PubMed ID: 4370454
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemistry and mechanism of new angiotensin UU antagonists: 8 C-phenylclycine analogues of [5-isoleucine] angiotensin].
    Wissmann H; Schoelkens B; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1974 Sep; 355(9):1083-96. PubMed ID: 4376799
    [No Abstract]   [Full Text] [Related]  

  • 8. Antagonism of peripheral and central effects of angiotensin II by (1-sarcosine, 8-isoleucine)angiotensin II.
    Sweet CS; Ferrario CM; Khosla MC; Bumpus FM
    J Pharmacol Exp Ther; 1973 Apr; 185(1):35-41. PubMed ID: 4348281
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypertension of renal origin: evidence for two different mechanisms.
    Brunner HR; Kirshman JD; Sealey JE; Laragh JH
    Science; 1971 Dec; 174(4016):1344-6. PubMed ID: 4332626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new, long-lasting competitive inhibitor of angiotensin.
    Türker RK; Hall MM; Yamamoto M; Sweet CS; Bumpus FM
    Science; 1972 Sep; 177(4055):1203-5. PubMed ID: 4341570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Central A II-antagonism in experimental hypertension].
    Schölkens BA
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():240. PubMed ID: 565989
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of a specific competitive antagonist of angiotensin II on arterial pressure and adrenal steroid secretion in dogs.
    Johnson JA; Davis JO
    Circ Res; 1973 May; 32():Suppl 1:159-68. PubMed ID: 4351357
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin analogs: the influence of sarcosine substituted in position 1.
    Hall MM; Khosla MC; Khairallah PA; Bumpus FM
    J Pharmacol Exp Ther; 1974 Jan; 188(1):222-8. PubMed ID: 4358436
    [No Abstract]   [Full Text] [Related]  

  • 14. A new class of angiotensin II analogs: substitution of sarcosine in position 7.
    Moore G; Oudeman E; Gorman P
    Proc West Pharmacol Soc; 1978; 21():261-6. PubMed ID: 693506
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of the antihypertensive effect of 1-Sar-8-Ala-angiotensin II during the acute phase of experimental renal hypertension.
    Pals DT; Fulton RW
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):20-30. PubMed ID: 4355711
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of exogenous angiotensin II on blood pressure in experimental nephrogenic and neurogenic-interoreceptive hypertension of rats].
    Nitschkoff S; Gnüchtel U; Jonas P; Wolnik L
    Dtsch Gesundheitsw; 1969 Dec; 24(51):2401-8. PubMed ID: 4316623
    [No Abstract]   [Full Text] [Related]  

  • 18. [Angiotensin antagonists].
    Takabatake T; Ohta H; Ishida Y; Hattori N
    Nihon Rinsho; 1985 May; 43(5):943-8. PubMed ID: 3897650
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibiting effect of (sarcosine-1-isoleucine-8)-angiotensin II in anesthesized rats].
    Gandarias JM; Casis L; Casis E; Gómez R; Iribar C
    Rev Esp Fisiol; 1987 Mar; 43(1):77-80. PubMed ID: 3616115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angiotensin blockade and hypertension].
    Stenbaek O
    Tidsskr Nor Laegeforen; 1974 Dec; 94(34-36):2396-7. PubMed ID: 4374772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.